Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Moor (Rotterdam, Netherlands), J. Oppenheimer (Rotterdam, Netherlands), G. Nakshbandi (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), A. Maitland- Van Der Zee (Amsterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands). Exhaled breath analysis using eNose technology in patients with sarcoidosis. 4395

Member's Comments

No comment yet.

Related content which might interest you: Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Exhaled breath temperature in COPD patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled breath CO and induced sputum in noninvasive assessment of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003 Exhaled breath molecular profiling in measuring inflammatory status in COPD Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled particles in healthy subjects and asthma patients – a new method for analysis of exhaled air Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Exhaled breath condensates and COPD Source: Eur Respir J 2009; 33: 1238 Year: 2009 Exhaled breath condensate: metabolomics Source: Eur Respir Monogr 2010; 49: 231-236 Year: 2010 Exhaled breath molecular profiling by electronic nose in non-pulmonary malignancies Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Exhaled breath condensate analysis in diagnostics of occupational asthma and rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Exhaled breath analyses in bronchial thermoplasty for severe asthma Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021